Skip to main content
IDYA logo

IDYA · IDEAYA Biosciences, Inc. · Analyst Estimates

Track IDYA — free
$25.56 -0.61 (-2.33%) At close · Nov 20 Q4 2021 earnings call transcript
Market Cap
$2.47B
Shares
96.69M
Volume · Nov 20 1.11M Avg daily vol (3M) 932.53K

Analyst Estimates

Compare analyst forecasts for IDEAYA Biosciences, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians. An EPS figure names its accounting basis, GAAP or Non-GAAP, where the capture records one, and compares only with the company's EPS on that basis; without one, the basis is not recorded.

Captured 2026-11-21 06:46 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-5.07
-4.76
-4.42
14
-4.81
-4.57
-4.61
-4.61
— —
2
3
Revenue
USD
Publication date not stated
25.66M
43.37M
75.70M
16
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-5.65
-4.22
-2.47
14
-4.22
-4.11
-4.10
-4.11
— —
4
5
Revenue
USD
Publication date not stated
17.70M
121.61M
264.86M
16
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-1.47
-1.19
-0.83
14
-1.17
-1.13
-1.13
-1.13
— —
1
2
Revenue
USD
Publication date not stated
0.00
16.63M
50.00M
14
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-1.41
-1.24
-1.01
5
-1.28
-1.21
-1.19
-1.19
1
1
0
0
Revenue
USD
Publication date not stated
0.00
6.57M
11.30M
7
— — — — — — — —
Key facts CIK 1676725 CUSIP 45166A102 13F (30d) 297 filings 263 filers Visit website Investor relations